Use of Simplified Lung Ultrasound Score for Predicting ICU Outcomes in Patients with Acute Respiratory Failure
1 other identifier
observational
72
0 countries
N/A
Brief Summary
This study aims to Primary Aims: Verify the predictability of the PLIS at admission in predicting major clinical outcomes including:
- ICU mortality (or discharge) and time to death (or discharge)
- Escalation of ventilatory support antibiotic therapy or supportive medications (inotropes, steroids, sedation, neuromuscular blockers). Secondary Aims:
- Determine the correlation between initial PLIS and the degree of disease severity (as evaluated per SOFA and APACHE II scores)
- Determine the correlation between initial PLIS and partial pressure of oxygen in arterial blood (PaO2) to Fraction of inspired oxygen (FiO2): PaO2/FiO2
- Explore the potential association between the type of ventilatory support, ventilatory settings and PLIS at different time points.
- Verify whether the site of consolidation (anterior vs. posterior lung zones) can reliably predict mortality in in ALI patients.
- Determine the correlation between the PLIS score and the degree of ALI as quantified by CT of the chest (whenever a CT study is available) at the time of admission.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2024
CompletedFirst Posted
Study publicly available on registry
November 7, 2024
CompletedStudy Start
First participant enrolled
November 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedNovember 7, 2024
October 1, 2024
11 months
October 5, 2024
November 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
ICU Mortality
Percentage of patients who will die during their ICU admission
60 days
Time to death/discharge
Number of days until the patient dies inside the ICU or becomes discharged from ICU
60 days
Secondary Outcomes (3)
Need for Therapy escalation: Ventilatory Support
60 days
Need for Therapy Escalation: Ventilatory seetings
60 days
Need for Therapy Escalation: Medications
60 days
Eligibility Criteria
Patients who are more than 18 years in repiratory failure in ICU and use of chest us in supine or semisupine position
You may qualify if:
- Age is or more than 18 years old.
- Admission to ICU in the first24 hours at time of recruitment to the study.
- Patients in respiratory failure \[PaO2 is less then 60 % mmHg\]
You may not qualify if:
- Co- existing chronic lung disease, pathology of which is known display abnormalities on US examination (interstitial lung diseases, bronchiectasis).
- Large pneumothorax or massive pleural effusion causing significant collapse and precluding proper visualization of underlying lung.
- Conditions that may interfere with lung ultrasound quality or probe contact such as marked obesity, severe chest wall deformities, burns or wounds.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Marchioni A, Castaniere I, Tonelli R, Fantini R, Fontana M, Tabbi L, Viani A, Giaroni F, Ruggieri V, Cerri S, Clini E. Ultrasound-assessed diaphragmatic impairment is a predictor of outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease undergoing noninvasive ventilation. Crit Care. 2018 Apr 27;22(1):109. doi: 10.1186/s13054-018-2033-x.
PMID: 29703214BACKGROUNDBiasucci DG, Buonsenso D, Piano A, Bonadia N, Vargas J, Settanni D, Bocci MG, Grieco DL, Carnicelli A, Scoppettuolo G, Eleuteri D, DE Pascale G, Pennisi MA, Franceschi F, Antonelli M; Gemelli Against COVID-19 Group. Lung ultrasound predicts non-invasive ventilation outcome in COVID-19 acute respiratory failure: a pilot study. Minerva Anestesiol. 2021 Sep;87(9):1006-1016. doi: 10.23736/S0375-9393.21.15188-0. Epub 2021 Jul 14.
PMID: 34263580BACKGROUND
Related Links
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident doctor Principal investigator
Study Record Dates
First Submitted
October 5, 2024
First Posted
November 7, 2024
Study Start
November 20, 2024
Primary Completion
October 1, 2025
Study Completion
October 1, 2025
Last Updated
November 7, 2024
Record last verified: 2024-10